Amiodarone Hydrochloride API Market
Amiodarone Hydrochloride API Market Scope:
Industry Analysis, Market Size, Growth, Trends Till
2031
Request Sample Report
Amiodarone Hydrochloride API Market Size and Growth
The Amiodarone Hydrochloride API market is characterized by steady growth, driven by rising cardiovascular diseases and increased demand for effective antiarrhythmic medications. The market size is estimated to exceed USD 300 million by 2025, reflecting expanding healthcare access and innovations in pharmaceuticals. Competitive dynamics emphasize quality and regulatory compliance. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Piramal Pharma Limited
◍ Olon
◍ Glenmark Pharma
◍ CTX Lifesciences
◍ PMC Isochem
◍ Zhejiang Sanmen Hengka
◍ United Pharma Industri
◍ Cambrex
The Amiodarone Hydrochloride API market features key players like Piramal Pharma, Olon, Glenmark Pharma, and others. These companies produce and supply Amiodarone APIs, driving market growth through innovations and strategic collaborations. Their contributions enhance availability and affordability, impacting the overall healthcare sector positively. Sales revenues include:
- Piramal Pharma: ~ $1 billion
- Glenmark Pharma: ~ $1.5 billion
- Sanofi: ~ $43 billion.
◍ Shanghai Pharmaceutical Group Co., Ltd
◍ Unichem Laboratories Limited
◍ Arevipharma
◍ Globe Quimica Ltda
◍ Sanofi
Request Sample Report
Market Segmentation
By Application
◍ Amiodarone Hydrochloride Tablets
◍ Amiodarone Hydrochloride Capsules
◍ Amiodarone Hydrochloride Tablets
Injection
By Product
◍ Purity>98%
◍ Purity<98%
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
